x

Search for a networks

* (*) mandatory field

ANITA: A Phase II Multicenter Study Comparing the Efficacy of the Oral Angiogenesis Inhibitor Nintedanib With the Intravenous Cytotoxic Compound Ifosfamide for Treatment of Patients With Advanced Metastatic Soft Tissue Sarcoma After Failure of Systemic Non-oxazaphosporine-based First Line Chemotherapy for Inoperable Disease

  • Type of network : Multinational clinical trials
  • Funded by an IRDiRC member
  • Geographic coverage : European
  • Funding body(ies) : EORTC 
  • Sponsor : Information not provided
  • Website
  • Coordinator of multinational clinical trial

  • INFORMATION NOT PROVIDED
  • Institution: Information not provided - BE
  • ADDRESS: NOT PROVIDED - BE
  • BELGIUM
  • More information
  • Phone  : -
  • Fax  : -
  • Sponsor of multinational clinical trial

  • EORTC
  • European Organisation for the Research and Treatment of Cancer
  • EORTC
  • Avenue Mounierlaan 83/11
  • 1200 BRUSSELS
  • BELGIUM
  • More information
  • Phone  : 0032 2 7741611
  • Fax  : 0032 2 7723545
  • Website
Last update: October 2018

Additional information

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.